Time to antibiotic administration and patient outcomes in community-acquired pneumonia: results from a prospective cohort study
- 1 March 2021
- journal article
- research article
- Published by Elsevier in Clinical Microbiology and Infection
- Vol. 27 (3) , 406-412
Abstract
No abstract availableKeywords
Funding Information
- Novo Nordisk Fonden
- Meso Scale Diagnostics
- Lundbeck Foundation
- Simons Foundation
- Pfizer
- Ministeriet Sundhed Forebyggelse
This publication has 27 references indexed in Scilit:
- Timing of antibiotic administration and outcomes of hospitalized patients with community-acquired and healthcare-associated pneumoniaClinical Microbiology and Infection, 2012
- Processes of Care and Outcomes for Community-Acquired PneumoniaThe American Journal of Medicine, 2011
- The Danish National Patient RegisterScandinavian Journal of Public Health, 2011
- Optimal caliper widths for propensity‐score matching when estimating differences in means and differences in proportions in observational studiesPharmaceutical Statistics, 2011
- Clinical and economic burden of community-acquired pneumonia among adults in EuropeThorax, 2010
- Severity assessment tools for predicting mortality in hospitalised patients with community-acquired pneumonia. Systematic review and meta-analysisThorax, 2010
- BTS guidelines for the management of community acquired pneumonia in adults: update 2009Thorax, 2009
- Admission Chest Radiograph Lacks Sensitivity in the Diagnosis of Community-Acquired PneumoniaThe American Journal of the Medical Sciences, 2009
- Factors impacting on length of stay and mortality of community-acquired pneumoniaClinical Microbiology and Infection, 2008
- Delayed Administration of Antibiotics and Atypical Presentation in Community-Acquired PneumoniaChest, 2006